Spontaneous Generation of Prion Infectivity in Fatal Familial Insomnia Knockin Mice

Neuron

Volumn 63, Issue 4, 2009, Pages 438-450

  Jackson, Walker S ^a   Borkowski, Andrew W ^a,b   Faas, Henryk ^c   Steele, Andrew D ^a   King, Oliver D ^a   Watson, Nicki ^a   Jasanoff, Alan ^c,d   Lindquist, Susan ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

HUMDISEASE; MOLNEURO; PROTEINS

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; EMBRYO; FATAL FAMILIAL INSOMNIA; GENE EXPRESSION; GENE MUTATION; INFECTION PREVENTION; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRION; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS TRANSMISSION; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; GENE KNOCK-IN TECHNIQUES; HUMANS; INSOMNIA, FATAL FAMILIAL; MICE; MICE, TRANSGENIC; PRIONS;

EID: 68949163542     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.07.026     Document Type: Article

References (71)

1. Aguzzi A., Heikenwalder M., and Polymenidou M. Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8 (2007) 552-561
2. Almer G., Hainfellner J.A., Brucke T., Jellinger K., Kleinert R., Bayer G., Windl O., Kretzschmar H.A., Hill A., Sidle K., et al. Fatal familial insomnia: a new Austrian family. Brain 122 (1999) 5-16
3. Aoki I., Wu Y.J., Silva A.C., Lynch R.M., and Koretsky A.P. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage 22 (2004) 1046-1059
4. Apetri A.C., Surewicz K., and Surewicz W.K. The effect of disease-associated mutations on the folding pathway of human prion protein. J. Biol. Chem. 279 (2004) 18008-18014
5. Asante E.A., Gowland I., Grimshaw A., Linehan J.M., Smidak M., Houghton R., Osiguwa O., Tomlinson A., Joiner S., Brandner S., et al. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J. Gen. Virol. 90 (2009) 546-558
6. Bar K.J., Hager F., Nenadic I., Opfermann T., Brodhun M., Tauber R.F., Patt S., Schulz-Schaeffer W., Gottschild D., and Sauer H. Serial positron emission tomographic findings in an atypical presentation of fatal familial insomnia. Arch. Neurol. 59 (2002) 1815-1818
7. Barron R.M., Thomson V., Jamieson E., Melton D.W., Ironside J., Will R., and Manson J.C. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 20 (2001) 5070-5078
8. Barron R.M., Campbell S.L., King D., Bellon A., Chapman K.E., Williamson R.A., and Manson J.C. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J. Biol. Chem. 282 (2007) 35878-35886
9. Benarroch E.E., and Stotz-Potter E.H. Dysautonomia in fatal familial insomnia as an indicator of the potential role of the thalamus in autonomic control. Brain Pathol. 8 (1998) 527-530
10. Brown P., Kenney K., Little B., Ironside J., Will R., Cervenakova L., Bjork R.J., San Martin R.A., Safar J., Roos R., et al. Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy. Ann. Neurol. 38 (1995) 245-253
11. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., and Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356 (1992) 577-582
12. Castilla J., Gutierrez-Adan A., Brun A., Doyle D., Pintado B., Ramirez M.A., Salguero F.J., Parra B., Segundo F.D., Sanchez-Vizcaino J.M., et al. Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein. J. Neurosci. 24 (2004) 5063-5069
13. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
14. Chesebro B. Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 66 (2003) 1-20
15. Chiesa R., Piccardo P., Ghetti B., and Harris D.A. Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21 (1998) 1339-1351
16. Collinge J., and Clarke A.R. A general model of prion strains and their pathogenicity. Science 318 (2007) 930-936
17. Collinge J., Palmer M.S., Sidle K.C., Gowland I., Medori R., Ironside J., and Lantos P. Transmission of fatal familial insomnia to laboratory animals. Lancet 346 (1995) 569-570
18. DeArmond S.J., Sanchez H., Yehiely F., Qiu Y., Ninchak-Casey A., Daggett V., Camerino A.P., Cayetano J., Rogers M., Groth D., et al. Selective neuronal targeting in prion disease. Neuron 19 (1997) 1337-1348
19. Deleault N.R., Harris B.T., Rees J.R., and Supattapone S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104 (2007) 9741-9746
20. Dossena S., Imeri L., Mangieri M., Garofoli A., Ferrari L., Senatore A., Restelli E., Balducci C., Fiordaliso F., Salio M., et al. Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60 (2008) 598-609
21. Fioriti L., Dossena S., Stewart L.R., Stewart R.S., Harris D.A., Forloni G., and Chiesa R. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280 (2005) 11320-11328
22. Fischer M., Rulicke T., Raeber A., Sailer A., Moser M., Oesch B., Brandner S., Aguzzi A., and Weissmann C. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15 (1996) 1255-1264
23. Gambetti P., and Lugaresi E. Conclusions of the symposium. Brain Pathol. 8 (1998) 571-575
24. Gambetti P., Parchi P., Petersen R.B., Chen S.G., and Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol. 5 (1995) 43-51
25. Haviv Y., Avrahami D., Ovadia H., Ben-Hur T., Gabizon R., and Sharon R. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin. Arch. Neurol. 65 (2008) 762-775
26. Hegde R.S., Tremblay P., Groth D., DeArmond S.J., Prusiner S.B., and Lingappa V.R. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402 (1999) 822-826
27. Hsiao K.K., Scott M., Foster D., Groth D.F., DeArmond S.J., and Prusiner S.B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250 (1990) 1587-1590
28. Hsiao K.K., Groth D., Scott M., Yang S.L., Serban H., Rapp D., Foster D., Torchia M., Dearmond S.J., and Prusiner S.B. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl. Acad. Sci. USA 91 (1994) 9126-9130
29. Huguenard J.R., and McCormick D.A. Thalamic synchrony and dynamic regulation of global forebrain oscillations. Trends Neurosci. 30 (2007) 350-356
30. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., and Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61 (1987) 3688-3693
31. Kovacs G.G., Trabattoni G., Hainfellner J.A., Ironside J.W., Knight R.S., and Budka H. Mutations of the prion protein gene phenotypic spectrum. J. Neurol. 249 (2002) 1567-1582
32. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., and Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
33. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., and Prusiner S.B. Synthetic mammalian prions. Science 305 (2004) 673-676
34. Lin Y.J., and Koretsky A.P. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn. Reson. Med. 38 (1997) 378-388
35. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., Ren S., Li X.J., Albin R.L., and Detloff P.J. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet. 10 (2001) 137-144
36. Little B.W., Brown P.W., Rodgers-Johnson P., Perl D.P., and Gajdusek D.C. Familial myoclonic dementia masquerading as Creutzfeldt-Jakob disease. Ann. Neurol. 20 (1986) 231-239
37. Lugaresi E., Medori R., Montagna P., Baruzzi A., Cortelli P., Lugaresi A., Tinuper P., Zucconi M., and Gambetti P. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N. Engl. J. Med. 315 (1986) 997-1003
38. Lugaresi E., Tobler I., Gambetti P., and Montagna P. The pathophysiology of fatal familial insomnia. Brain Pathol. 8 (1998) 521-526
39. Manetto V., Medori R., Cortelli P., Montagna P., Tinuper P., Baruzzi A., Rancurel G., Hauw J.J., Vanderhaeghen J.J., Mailleux P., et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 42 (1992) 312-319
40. Manson J.C., Clarke A.R., Hooper M.L., Aitchison L., McConnell I., and Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8 (1994) 121-127
41. Manson J.C., Jamieson E., Baybutt H., Tuzi N.L., Barron R., McConnell I., Somerville R., Ironside J., Will R., Sy M.S., et al. A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 18 (1999) 6855-6864
42. Manuelidis L. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J. Cell. Biochem. 100 (2007) 897-915
43. McCormack J.E., Baybutt H.N., Everington D., Will R.G., Ironside J.W., and Manson J.C. PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease. Gene 288 (2002) 139-146
44. Medori R., Montagna P., Tritschler H.J., LeBlanc A., Cortelli P., Tinuper P., Lugaresi E., and Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42 (1992) 669-670
45. Mochizuki T., Klerman E.B., Sakurai T., and Scammell T.E. Elevated body temperature during sleep in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R533-R540
46. Moore R.C., Redhead N.J., Selfridge J., Hope J., Manson J.C., and Melton D.W. Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Biotechnology (N. Y.) 13 (1995) 999-1004
47. Nazor K.E., Kuhn F., Seward T., Green M., Zwald D., Purro M., Schmid J., Biffiger K., Power A.M., Oesch B., et al. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J. 24 (2005) 2472-2480
48. Parchi P., Castellani R., Cortelli P., Montagna P., Chen S.G., Petersen R.B., Manetto V., Vnencak-Jones C.L., McLean M.J., Sheller J.R., et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann. Neurol. 38 (1995) 21-29
49. Parchi P., Petersen R.B., Chen S.G., Autilio-Gambetti L., Capellari S., Monari L., Cortelli P., Montagna P., Lugaresi E., and Gambetti P. Molecular pathology of fatal familial insomnia. Brain Pathol. 8 (1998) 539-548
50. Polymenidou M., Stoeck K., Glatzel M., Vey M., Bellon A., and Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4 (2005) 805-814
51. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144
52. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA 95 (1998) 13363-13383
53. Reder A.T., Mednick A.S., Brown P., Spire J.P., Van Cauter E., Wollmann R.L., Cervenakova L., Goldfarb L.G., Garay A., Ovsiew F., et al. Clinical and genetic studies of fatal familial insomnia. Neurology 45 (1995) 1068-1075
54. Riek R., Wider G., Billeter M., Hornemann S., Glockshuber R., and Wuthrich K. Prion protein NMR structure and familial human spongiform encephalopathies. Proc. Natl. Acad. Sci. USA 95 (1998) 11667-11672
55. Sasaki K., Doh-ura K., Wakisaka Y., Tomoda H., and Iwaki T. Fatal familial insomnia with an unusual prion protein deposition pattern: an autopsy report with an experimental transmission study. Neuropathol. Appl. Neurobiol. 31 (2005) 80-87
56. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., and Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73 (1993) 979-988
57. Selfridge J., Pow A.M., McWhir J., Magin T.M., and Melton D.W. Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene. Somat. Cell Mol. Genet. 18 (1992) 325-336
58. Sigurdson C.J., Manco G., Schwarz P., Liberski P., Hoover E.A., Hornemann S., Polymenidou M., Miller M.W., Glatzel M., and Aguzzi A. Strain fidelity of chronic wasting disease upon murine adaptation. J. Virol. 80 (2006) 12303-12311
59. Sigurdson C.J., Nilsson K.P., Hornemann S., Heikenwalder M., Manco G., Schwarz P., Ott D., Rulicke T., Liberski P.P., Julius C., et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. USA 106 (2009) 304-309
60. Simon E.S., Kahana E., Chapman J., Treves T.A., Gabizon R., Rosenmann H., Zilber N., and Korczyn A.D. Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann. Neurol. 47 (2000) 257-260
61. Somerville R.A. TSE agent strains and PrP: reconciling structure and function. Trends Biochem. Sci. 27 (2002) 606-612
62. Steele A.D., Jackson W.S., King O.D., and Lindquist S. The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. Proc. Natl. Acad. Sci. USA 104 (2007) 1983-1988
63. Steriade M., and Timofeev I. Neuronal plasticity in thalamocortical networks during sleep and waking oscillations. Neuron 37 (2003) 563-576
64. Supattapone S., Muramoto T., Legname G., Mehlhorn I., Cohen F.E., DeArmond S.J., Prusiner S.B., and Scott M.R. Identification of two prion protein regions that modify scrapie incubation time. J. Virol. 75 (2001) 1408-1413
65. Tateishi J., Brown P., Kitamoto T., Hoque Z.M., Roos R., Wollman R., Cervenakova L., and Gajdusek D.C. First experimental transmission of fatal familial insomnia. Nature 376 (1995) 434-435
66. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., and Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83 (1995) 79-90
67. Telling G.C., Parchi P., DeArmond S.J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., and Prusiner S.B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274 (1996) 2079-2082
68. Thackray A.M., Klein M.A., Aguzzi A., and Bujdoso R. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76 (2002) 2510-2517
69. Weissmann C., and Flechsig E. PrP knock-out and PrP transgenic mice in prion research. Br. Med. Bull. 66 (2003) 43-60
70. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.L., Torchia M., Carlson G.A., and Prusiner S.B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76 (1994) 117-129
71. Zarranz J.J., Digon A., Atares B., Rodriguez-Martinez A.B., Arce A., Carrera N., Fernandez-Manchola I., Fernandez-Martinez M., Fernandez-Maiztegui C., Forcadas I., et al. Phenotypic variability in familial prion diseases due to the D178N mutation. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1491-1496